Utilize These 5 Provider Resources for Opioid Crisis Questions

Why This Topic Matters

The opioid crisis continues to affect patients, providers, and enforcement activity, making federal guidance and education resources important for staying informed. This article helps readers identify where to find official information on prevention, prescribing support, monitoring tools, and related regulatory topics.

Article Sections

1. Opioid crisis background and enforcement context

   Introduces the opioid epidemic as a public health issue and explains why provider-facing guidance and federal attention are relevant. It also frames the article around practical online resources for clinicians and organizations.

2. Federal resource overview

   Summarizes five federal websites and tools that address different aspects of the opioid epidemic. The section points readers to resources from multiple agencies covering prevention, monitoring, and health IT support.

3. HHS opioid resources

   Describes the Department of Health and Human Services resource page and the general types of materials it provides for practitioners. The focus is on broad federal support related to the opioid crisis.

4. CDC opioid overdose resources

   Covers the Centers for Disease Control resource area, including background information, statistics, and provider-oriented tools. The section emphasizes the CDC’s public health perspective on overdose.

5. Medicare Part D opioid prescribing mapping tool

   Introduces an interactive CMS tool that offers geographic views of de-identified Medicare Part D opioid prescribing data. The section explains that the tool helps users examine local patterns and trends.

6. Opioid epidemic and health IT

   Summarizes an ONC Health IT Playbook section focused on technology-related resources for clinicians. It highlights the connection between electronic prescribing, monitoring programs, and opioid-related health IT guidance.

7. FDA REMS for opioid analgesics

   Describes FDA resources tied to opioid safety, pain management, and related educational materials. The section presents the FDA as another federal source of opioid-related guidance for providers.